Medical Microneedle Diagnostics: Devices, Targets, Technology & Markets is a comprehensive evaluation and analysis of the technology, markets and competitive landscape providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, fabrication/manufacturing technologies, and commercial opportunities across the spectrum of microneedle diagnostic architectures, designs, classes and form factors. Provider organization business managers, healthcare administrators and investors will also benefit from this study
Converging Factors Driving Medical Microneedle Diagnostics
Microneedle technology is attaining commercial viability at a time when healthcare providers are faced with new challenges as they assess ways to incorporate companion diagnostics into their practice areas.
Microneedle technology has the potential to address the growing trend toward point of care diagnostics and ambulatory patient monitoring by allowing the precise detection of biomarkers and analytes in fluids and tissues located below the skin. To succeed, developers must refine the techniques available and in development for sampling very small quantities and/or concentrations of analytes and biomarkers and advance the design integration of microneedles into commercially viable diagnostic platform.
What You Will Learn
- What companies are active in the microneedle diagnostics segments, what distinguishes their technology, and what is their market presence?
- Who are the microneedle diagnostic device developers/suppliers, and what are their capabilities?
- What are the major factors that are influencing demand for microneedle diagnostics?
- What are the essential design factors, material selection issues, technologies and market development issues for diagnostic microneedle products?
- What are the important healthcare markets for microneedle diagnostics? What is their market potential?
- What are the significant economic, technology, and regulatory factors affecting the market for diagnostic microneedles?
Table of Contents
Executive Summary
Companies Mentioned
- Aptamer Group
- Bico Group
- EnABLES European Research Infrastructure
- Fujifilm
- Georgia Institute of Technology (USA)
- Imperial College of London (UK)
- Kyoto University (Japan)
- LTS
- Massachusetts Institute of Technology (USA)
- microLIQUID
- Mindera Health
- MyLife Technologies B.V.
- Novinject
- Queens University (Belfast, Ireland)
- Sandia National Laboratories (USA)
- Seoul National University (Korea)
- Seventh Sense Biosystems
- Stanford University
- Swansea University (UK)
- Sysmex
- Tasso
- Tyndall National Institute (Ireland)
- Universal Biosensors
- Universita di Pisa (Italy)
- University of Brighton (UK)
- University of Florida (USA)
- University of Queensland (Australia)
- University of Reading (UK)
- University of Texas (USA)
- University of Washington (USA)
